Combination therapy for sexual dysfunction: Integrating sex therapy and pharmacotherapy

Handbook of Sexual Dysfunction

Volumn , Issue , 2005, Pages 13-42

  Perelman, Michael A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956933995     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (59)

1. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston: Little Brown, 1970.
2. Kaplan HS. The New Sex Therapy. New York: Brunner/Mazel, 1974.
3. Norcross JC, Guest Editor. Psychotherapy: Special Issue: Empirically Supported Therapy Relationships: Summary Report of the Division 29 Task Force. Vol. 38, No. 4, Winter, 2001.
4. Kaplan HS, Perelman MA. The physician and the treatment of sexual dysfunction. In: Usdin G, Lewis J, eds. Psychiatry in General Medical Practice. New York, NY: McGraw-Hill, 1979.
5. Perelman MA. Premature ejaculation. In: Lieblum S, Pervin L, eds. Principles and Practice of Sex Therapy. New York, NY: Guilford Press, 1980.
6. Perelman MA. The urologist and cognitive behavioral sex therapy. Contemp Urol 1994; 6:27–33.
7. Perelman MA. Commentary: Pharmacological agents for ED & the human sexual response cycle. J Sex Marital Ther 1998; 24:309–312.
8. Zilbergeld B. The New Male Sexuality. New York: Bantam Books, 1992.
9. Heiman JR, Meston CM. Empirically validated treatment for sexual dysfunction. In: Rosen R, Davis C, Ruppel H, eds. Annual Review of Sex Research. Mount Vernon, IA: The Society for the Scientific Study of Sexuality, 1998.
10. Perelman MA. Rehabilitative sex therapy for organic impotence. In: Segraves T, Haeberle E, eds. Emerging Dimensions of Sexology. NY: Praeger Publications, 1984.
11. Rosen RC, Ashton A. Prosexual drugs: empirical status of the “New Aphrodisiacs.” Arch Sexual Behav 1993; 22:521–543.
12. Carson CC, Burnett AL, Levine LA, Nehra A. The efficacy of sildenafil citrate (sildenafil) in clinical populations: an update. Urology 2002; 60(suppl 2B).
13. Hellstrom W. Vardenafil: a new approach to the treatment of erectile dysfunction, Curr Urol Rep, Curr Sci Inc 2003; 4:479–487
14. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168(4).
15. Althof SE. Therapeutic weaving: the integration of treatment techniques. In: Levine SB, ed. Handbook of Clinical Sexuality for Mental Health Professionals. New York: Brunner-Routledge, 2003:359–376.
16. Levine SB. Erectile dysfunction: Why drug therapy isn’t always enough. Cleveland Clinic J Med 2003; 70(3).
17. Perelman MA. The impact of the new sexual pharmaceuticals on sex therapy. Curr Psychiatry Rep 2001; 3(3).
18. Goldstein I, Lue T, Padma-Nathan H, Rosen R et al. Oral sildenafil in the management of erectile dysfunction. New Engl J Med 1998; 338:1397–1404.
19. A Sand et al. Males, ISSIR 2002.
20. Perelman M. Sex coaching for physicians: combination treatment for patient and partner. Int J Impotence Res: J Sexual Med 2003; 15(suppl 5).
21. Shabsigh R, Perelman M, Laumann E, Lockhart D. Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. Br J Urol Inter September/October 2004; 1055–1065.
22. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:51–61.
23. Althof S. When an erection alone is not enough: biopsychosocial obstacles to lovemaking. Int J Impotence Res 2002; 14(suppl 1):S99–S104. Nature Publishing Group 2002.
24. Keller MB et al. A comparison of nefazodone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New Engl J Med 2000; 342:1462–1470.
25. Seligman MEP. The effectiveness of psychotherapy: the Consumer Reports study. Am Psychol 1995; 50:965–974.
26. Nathan PE, Gorman JM. A guide to treatments that work. New York: Oxford University Press, 1998.
27. AUA BPH Guidelines Panel. The Management of Benign Prostatic Hyperplasia, American Urological Association Education and Research, Inc. Washington, DC, 2003.
28. Turner LA, Althof SE, Levine SB, Risen CB, Bodner DR, Cursh ED, Resnick MI. Self-injection of papaverine and phentolamine in the treatment of psychogenic impotence. J Sex Marital Therapy 1989; 15:163–170.
29. Kaplan HS. The combined use of sex therapy and intra-penile injections in the treatment of impotence. J Sex Marital Therapy 1990; 16:4.
30. Hartmann U, Langer D. Combination of psychosexual therapy and intra-penile injections in the treatment of erectile dysfunctions: rationale and predictors of outcome. J Sex Education Therapy 1993; 19:1–12.
31. Colson MH. Intracavernous injections and overall treatment of erectile disorders: a retrospective study. Sexologies 1996; 5.
32. Lottman PE, Hendriks JC, Vruggink PA, Meuleman EJ. The impact of marital satisfaction and psychological counselling on the outcome of ICI-treatment in men with ED. Int J Impot Res Jun 1998; 10(2):83–87.
33. Wylie KR, Hallam-Jones R, Walters S. The potential benefit of vacuum devices augmenting psychosexual therapy for erectile dysfunction: RCT. J Sex Marital Therapy 2003; 29(3).
34. McCarthy BW. Integrating sildenafil into cognitive-behavioral couple’s sex therapy. J Sex Educ Ther 1998; 23:302–308.
35. Segraves RT. Case Report, two additional uses for sildenafil in psychiatric patients. J Sex Marital Therapy 1999; 25:265–266.
36. Perelman MA. Integrating sildenafil and sex therapy: unconsummated marriage secondary to ED and RE. J Sex Education Therapy 2001; 26:13–21.
37. Perelman MA. FSD partner issues: expanding sex therapy with sildenafil. J Sex Mar Ther 2002; 28(s):195–204.
38. Lieblum S, Pervin L, Cambell E. The treatment of vaginismus: success and failure. In: Leiblum SR, Rosen RC, eds. Principles and Practice of Sex Therapy: Update for the 1990s. New York: Guilford Press, 1989:113–140.
39. Hawton K. Integration of treatments for male erectile dysfunction. Lancet 1998; 351:728.
40. Rosen RC. Medical and psychological interventions for erectile dysfunction. Toward a combined treatment approach. In: Leiblum SR, Rosen RC, eds. Principles and Practice of Sex Therapy. 3rd ed. New York: Guildford Press, 2000.
41. Lue TF, Basson R, Rosen R et al (eds) Sexual medicine: sexual dysfunction in men and women. Health Publications, Paris, 2004.
42. Perelman M, McMahon C, Barada J. Evaluation and treatment of ejaculatory disorders, in atlas of male sexual dysfunction [Ed: Lue, T.], Current Medicine, Inc., Philadelphia, Pennsylvania, 2004.
43. Perelman MA. Retarded ejaculation. Current Sexual Health Reports, 2004: 95–101.
44. Goldstein I. The process of care model for evaluation and treatment of erectile dysfunction. Int J Impotence Res 1999; 11:59–74.
45. Nurmberg G. Treatment of antidepressant-associated sexual dysfunction with sildenafil. J Am Med Assoc 2003; 289:56–64.
46. Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001; 158:1623–1630.
47. A Balon et al. J Clin Psychiatry 1993; 54:209.
48. Physicians’ Desk Reference 57, Edition 2003, Thomson PDR, Montvale, NJ, 2003.
49. Segraves RT, Croft H, Kavoussi R, Ascher JA. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther 2001; 27(3):303–316.
50. McCarthy B. Relapse prevention strategies and techniques with erectile dysfunction. J Sex Mar Ther 2001; 27(1):1–8.
51. Summer F et al. Which PDE-5 inhibitor do patients prefer? A comparator randomized multicenter study of sildenafil, tadalafil and vardenafil. Presented at 6th Congress of the European Society for Sexual Medicine, Istanbul, Turkey, 2003.
52. Perelman MA. Pharmaceutical choice and sexual script analysis. Br J Urol Inter 2005; In press.
53. Gagnon J, Rosen R, Leiblum S. Cognitive and social science aspects of sexual dysfunction: sexual scripts in therapy. J Sex Marital Therapy 1982; 8(1):44–56.
54. Barada JA. Successful Salvage of “Sildenafil (Sildenafil) Failures”: Benefits of Patient Education and Re-Challenge with Sildenafil. Presented at the 4th Congress of the European Society for Sexual and Impotence Research, Sept. 30–Oct. 3, 2001, Rome, Italy.
55. Hatzichristou D. Sildenafil failures may be due to inadequate instructions and follow-up: a study of 100 non-responders. Int J Impotence Res 2001; 13:32.
56. Perelman MA. Pharmaceutical choice and sexual script analysis. Br J Urol Inter 2005; In press.
57. Albaugh J et al. Health care clinicians in sexual health medicine: focus on erectile dysfunction. Urologic Nursing 2002; 22(4).
58. Gittelman M. Personal communication, 2003.
59. Padma-Nathan H. Personal communication, 2003.